Focal adhesion kinase inhibitors, a heavy punch to cancer | SpringerLink
Targeting FAK in anticancer combination therapies | Nature Reviews Cancer
PND-1186 (VS-4718) | ≥99%(HPLC) | Selleck | FAK inhibitor
![PDF] Targeting FAK in human cancer: from finding to first clinical trials. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/26a9977be69e5b652809520c612c75a481f39781/9-Table2-1.png "PDF] Targeting FAK in human cancer: from finding to first clinical trials. | Semantic Scholar")
PDF] Targeting FAK in human cancer: from finding to first clinical trials. | Semantic Scholar
Molecules | Free Full-Text | Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy
PYK2/FAK inhibitors reverse hypoxia-induced drug resistance in multiple myeloma | Haematologica
The FAK inhibitor BI 853520 exerts anti-tumor effects in breast cancer | Oncogenesis
Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment - ScienceDirect
Targeting FAK in anticancer combination therapies | Nature Reviews Cancer
Pharmacological FAK Inhibitors. | Download Table
Summary of FAK signaling inhibitors in clinical trials. | Download Scientific Diagram
FAK Inhibition | FAK Inhibitor Review
Understanding the Roles of FAK in Cancer: Inhibitors, Genetic Models, and New Insights - Hyunho Yoon, Joshua P. Dehart, James M. Murphy, Ssang-Taek Steve Lim, 2015
FAK inhibitors with anti-tumor activity in preclinical studies and... | Download Scientific Diagram
![PDF] Targeting FAK in human cancer: from finding to first clinical trials. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/26a9977be69e5b652809520c612c75a481f39781/3-Figure1-1.png "PDF] Targeting FAK in human cancer: from finding to first clinical trials. | Semantic Scholar")
PDF] Targeting FAK in human cancer: from finding to first clinical trials. | Semantic Scholar
IJMS | Free Full-Text | The Crosstalk between FAK and Wnt Signaling Pathways in Cancer and Its Therapeutic Implication
Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment - ScienceDirect
PF-562271 | ≥99%(HPLC) | Selleck | FAK inhibitor
Molecules | Free Full-Text | Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy
Focal Adhesion Kinase Promotes the Progression of Aortic Aneurysm by Modulating Macrophage Behavior | Arteriosclerosis, Thrombosis, and Vascular Biology
![PDF] Targeting FAK in human cancer: from finding to first clinical trials. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/26a9977be69e5b652809520c612c75a481f39781/2-Table1-1.png "PDF] Targeting FAK in human cancer: from finding to first clinical trials. | Semantic Scholar")
PDF] Targeting FAK in human cancer: from finding to first clinical trials. | Semantic Scholar
Pipeline | Current Clinical Trials | Verastem Oncology
Molecules | Free Full-Text | Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy
Design, Synthesis, and Biological Evaluation of 4-Arylamino Pyrimidine Derivatives as FAK Inhibitors and Tumor Radiotracers | Molecular Pharmaceutics
Molecules | Free Full-Text | Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy
